Literature DB >> 26792388

Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas - a prospective study.

B Børresen1, L N Nielsen1, L R Jessen1, A T Kristensen1, M Fredholm1, S Cirera1.   

Abstract

Cancer is a prevalent cause of mortality in Bernese mountain dogs (BMDs). Circulating microRNAs (miRNAs) are found in blood and have been identified as promising biomarkers in various neoplastic diseases in humans. In the current study, the expression profile of different types of miRNAs was investigated in healthy BMDs and BMDs with cancer. Seven healthy and six non-treated BMDs with cancer [four with disseminated histiocytic sarcomas (DHS)] were enrolled in this study. Clinical evaluations including physical examination, blood analysis, urinalysis and diagnostic imaging were performed on all dogs. Twenty-four different miRNAs were profiled from RNA isolated from whole blood preserved in PAXgene® tubes using quantitative real-time PCR (qPCR). The miRNA let-7g was significantly down-regulated in dogs with cancer (P = 0.002) and dogs with DHS (P = 0.011) compared with healthy controls. This miRNA is a known tumour suppressor and further analyses are warranted to assess its value as a non-invasive biomarker for early detection of different types of cancer in BMDs.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; canine; let-7g; oncology

Mesh:

Substances:

Year:  2016        PMID: 26792388     DOI: 10.1111/vco.12196

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  2 in total

1.  Evaluation of fecal microRNA stability in healthy cats.

Authors:  Janne G Lyngby; Annemarie T Kristensen; Merete Fredholm; Lise N Nielsen; Susanna Cirera
Journal:  Vet Clin Pathol       Date:  2019-06-26       Impact factor: 1.180

Review 2.  Epigenetic Mechanisms in Canine Cancer.

Authors:  Pedro Luiz Porfirio Xavier; Susanne Müller; Heidge Fukumasu
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.